Lotz Christopher L.
Insider CIK 1812553 · QLGN Vice President of Finance, CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QLGN Qualigen Therapeutics, Inc | A Award deriv | 2022-07-11 | 2022-08-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | P Buy | 2021-04-16 | 2021-04-19 | 2,700 | $1.86 | $5.0K | 12,541 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | A Award deriv | 2020-06-06 | 2020-06-08 | 600,000 | — | $0 | 600,000 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other deriv | 2020-05-22 | 2020-05-27 | 3,543 | — | $0 | 3,543 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other deriv | 2020-05-22 | 2020-05-27 | 22,142 | — | $0 | 22,142 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other deriv | 2020-05-22 | 2020-05-27 | 29,847 | — | $0 | 29,847 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other deriv | 2020-05-22 | 2020-05-27 | 22,142 | — | $0 | 22,142 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other | 2020-05-22 | 2020-05-27 | 9,841 | — | $0 | 9,841 | SEC↗ |